Michael Weickert, Ph.D

Michael Weickert, Ph.D. is an experienced pharmaceutical executive with over 30 years of experience in drug development at both public and private companies.1 He is currently the CEO of Fe Pharmaceuticals, a company focused on developing iron management polymers for treating serious diseases.5

Career Highlights

Leadership Roles::

• CEO of Fe Pharmaceuticals (current position)5
• CEO of Pacylex Pharmaceuticals2
• CEO of illumiSonics, Sonescence, and SEA Medical Systems1
• Chief Business Officer (CBO) of Strategent Life Sciences, Corium, and Therashock1
• Chief Operating Officer (COO) of Greenfire Bio and Ohm Oncology14
• Vice President of Development at SciDose and Auspex1
• Senior Program Executive at Nektar Therapeutics4

Notable Achievements::

• Drove oncology product development, including Phase III/NDA for Targretin for Cutaneous T-cell Lymphoma1
• Obtained Orphan Drug and Fast Track designations for oncology-related products in the US and EU1
• Led development of Nektar's flagship proprietary product, inhaled amphotericin B4
• Created and built a new anti-infective business unit at Nektar Therapeutics4

Education

• Ph.D. in Genetics from the University of Wisconsin-Madison23
• M.S. in Genetics from the University of Wisconsin-Madison3
• M.S. in Biology from Northern Illinois University3
• B.A. in Biology from Southern Illinois University, Carbondale3

Additional Information

Dr. Weickert has extensive experience in various aspects of drug development, including preclinical development, clinical trials, regulatory interactions, and business planning.14 He has worked on a wide range of therapeutic areas, with a particular focus on oncology and anti-infectives.45 Prior to his career in the pharmaceutical industry, he worked at the National Cancer Institute at NIH.2